The table below shows Sarepta Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.20B
$1.90B
$1.24B
$933.01M
$701.89M
$540.10M
Cost of revenue
$25.50M
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$491.72M
SRPT annual revenue (10-K history)
Sarepta Therapeutics, Inc. reported annual revenue of $2.20B for fiscal year 2025. That is up 15.6% from $1.90B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.42M (FY 2016) to $2.20B. Figures come from the company's audited annual reports as filed with the SEC.
